2025-07-02 | Company
Sever Pharma Solutions Appoints Fredrik Hultenius as New CEO
We are pleased to announce the appointment of Fredrik Hultenius as new Chief Executive Officer, effective July 1st, 2025.
2025-07-02 | Company
We are pleased to announce the appointment of Fredrik Hultenius as new Chief Executive Officer, effective July 1st, 2025.
2025-06-30 | Company
We’re delighted to share insights from Tony Listro, VP and Site Head of Sever Pharma Solution following a great interview at BIO2025.
2025-06-17 | Company
We’re delighted to share insights from Tony Listro, VP and Site Head of Sever Pharma Solution following a great interview at BIO2025.
2025-04-23 | Company
In 2024, our Putnam site fully commissioned and qualified two new High Potent API processing suites.
2025-04-07 | Company
Sever Pharma Solutions is pleased to announce Ulrike Foley as the new Head of Global Business Development and Marketing.
2025-03-26 | Company
Sever Pharma Solutions is proud to be prominently featured in the 2024 Citeline Annual Report on Medicon Valley.
2024-11-19 | Company
The year 2023 has proven successful, especially in the United States. Revenues increased by 50 percent, with significant improvements in profit margins.
2024-11-14 | Company
Sever Pharma Solutions is proud to be prominently featured in the 2024 Citeline Annual Report on Medicon Valley.
2024-08-30 | Company
We are happy to announce that Stefan Petersson has been appointed as Global HR Director.
2024-08-01 | Company
Here you can read the latest press release from The Global Fund and The Children’s Investment Fund Foundation, explaining how PrEP rings, manufactured in Sweden by Sever Pharma Solutions, make a difference for women in Africa.